Geron Corporation (GERN)
NASDAQ·Healthcare·Biotechnology
$1.34
+5.08%
Mkt Cap $827.56M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$5.89
Range $4.00 – $8.00
Implied Upside
+339.6%
Consensus $5.89 vs current $1.34
NASDAQ·Healthcare·Biotechnology
$1.34
+5.08%
Mkt Cap $827.56M
No recent rating data.
Price Target (11 analysts)
$5.89
Range $4.00 – $8.00
+339.6%
Consensus $5.89 vs current $1.34